UK markets open in 7 hours 12 minutes
NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
79.06 -0.20 (-0.25%) GOLD FUTURES
2,425.10 -0.80 (-0.03%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
55,232.52 -906.47 (-1.61%)
ADC Therapeutics SA (ADCT)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 395.49M |
| Enterprise value | 285.53M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 4.92 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 4.16 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 61.18% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 6.0400 |
| 52-week low 3 | 0.3600 |
| 50-day moving average 3 | 4.4798 |
| 200-day moving average 3 | 2.4656 |
Share statistics
| Avg vol (3-month) 3 | 560.79k |
| Avg vol (10-day) 3 | 546.3k |
| Shares outstanding 5 | 96.23M |
| Implied shares outstanding 6 | 106.03M |
| Float 8 | 63.23M |
| % held by insiders 1 | 20.80% |
| % held by institutions 1 | 40.41% |
| Shares short (30 Apr 2024) 4 | 857.61k |
| Short ratio (30 Apr 2024) 4 | 1.89 |
| Short % of float (30 Apr 2024) 4 | 1.59% |
| Short % of shares outstanding (30 Apr 2024) 4 | 1.04% |
| Shares short (prior month 28 Mar 2024) 4 | 993.08k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -186.19% |
Management effectiveness
| Return on assets (ttm) | -24.08% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 68.62M |
| Revenue per share (ttm) | 0.83 |
| Quarterly revenue growth (yoy) | -4.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -148.13M |
| Net income avi to common (ttm) | -227.28M |
| Diluted EPS (ttm) | -2.5100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 234.28M |
| Total cash per share (mrq) | 2.83 |
| Total debt (mrq) | 122.9M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 4.61 |
| Book value per share (mrq) | -2.35 |
Cash flow statement
| Operating cash flow (ttm) | -147.39M |
| Levered free cash flow (ttm) | -89.98M |
© 2024 Yahoo. All rights reserved.